Chronic Kidney Disease Market Forecasts in 19 Major Countries 2016-2026

Dublin, April 12, 2016 -- Research and Markets has announced the addition of the "Chronic Kidney Disease Forecast in 19 Major Markets 2016-2026" report to their offering.

Chronic kidney disease (CKD), also known as chronic renal disease, is characterised by progressive loss of kidney function over time. CKD is defined as persisting kidney damage or a glomerular filtration rate (GFR) of <60 mL/min/1.73 m2 for = 3 months. This damage refers to any renal pathology that has the potential to cause a reduction in renal functional capacity, such as GFR.

This report provides the current prevalent population for CKD across 19 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan, India, Turkey, Mexico, Australia, Canada, Norway, Ireland, Netherlands, Poland, South Korea and China) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team, several of the main symptoms and co-morbidities of CKD have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for CKD include:

- Hypertension
- Diabetes
- Chronic heart failure
- Anaemia
- Hyperphosphatemia
- Increased risk of infection
- End stage renal disease
- Acute kidney injury

Reasons to Buy:

- Able to quantify patient populations in global CKD's market to target the development of future products, pricing strategies and launch plans.
- Gain further insight into the prevalence of the subdivided types of CKD and identify patient segments with high potential.
- Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
- Provide a level of understanding on the impact from specific co-morbid conditions on CKD's prevalent population.
- Identify sub-populations within CKD which require treatment.
- Gain an understanding of the specific markets that have the largest number of CKD patients.

Key Topics Covered:

1. Introduction

2. Cause of the Disease

3. Risk Factors & Prevention

4. Diagnosis of the Disease

5. Variation by Geography/Ethnicity

6. Disease Prognosis & Clinical Course

7. Key Co-morbid Conditions/Features Associated with the Disease

8. Methodology for Quantification of Patient Numbers
- Additional data available on request

9. Top-Line Prevalence for Chronic Kidney Disease

10. Features of Chronic Kidney Disease Patients
- CKD by Stage of Disease
- ESRD Therapy
- Associated Conditions of CKD Patients
- Associated Conditions of ESRD Patients

11. Abbreviations used in the Report

12. Patient-Based Offering

13. Online Pricing Data and Platforms

14. References

15. Appendix

For more information visit http://www.researchandmarkets.com/research/63xwdp/chronic_kidney

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]

         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716